Research Article| Volume 59, ISSUE 5, P446-448, May 1985

Control of pain with meclofenamate sodium following removal of an impacted molar

      This paper is only available as a PDF. To read, Please Download here.


      The analgesic effectiveness of meclofenamate sodium (Meclomen)
      Meclomen (meclofenamate sodium), a product of Parke-Davis, Division of Warner-Lambert, Morris Plains, N. J.
      Meclomen (meclofenamate sodium), a product of Parke-Davis, Division of Warner-Lambert, Morris Plains, N. J.
      at two dose levels, 200 mg and 100 mg, was compared with the effectiveness of a placebo and aspirin, 600 mg, in a double-blind study of 174 adult outpatients who had undergone removal of impacted third molars. When compared with the placebo, meclofenamate sodium at either dose level produced a significantly greater reduction in pain intensity, greater pain relief, fewer withdrawals for inefficacy, greater percentage of patients who considered their medication effective, and greater percentage of patients considered by the investigator to have received drug-attributable benefits. In comparison with aspirin, 600 mg, meclofenamate sodium at either 200 mg or 100 mg produced significantly greater reduction in pain intensity and greater pain relief. The other measures of efficacy showed no significant differences between the two drugs. Side effects were minimal in all treatment groups. Meclofenamate sodium appears to be a safe and effective analgesic for the control of pain.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Cooper SA
        New peripherally-acting oral analgesic agents.
        Ann Rev Pharmacol Toxicol. 1983; 23: 617-647
        • Kantor TG
        Control of pain by nonsteroidal anti-inflammatory drugs.
        Med Clin North Am. 1982; 66: 1053-1059
        • Higgs GA
        Arachidonic acid metabolism, pain and hyperalgesia: the mode of action of non-steroidal mild analgesics.
        Br J Clin Pharmacol. 1980; 10: 233S-235S
        • Ferreira SH
        Peripheral analgesia: mechanism of the analgesic action of aspirin like drugs and opiate-antagonists.
        Br J Clin Pharmacol. 1980; 10: 237S-245S
        • Craig CL
        • Buchanan WW
        Antirheumatic drugs: clinical pharmacology and therapeutic use.
        Drugs. 1980; 20: 453-484
        • Cooper SA
        • Beaver WT
        A model to evaluate mild analgesics in oral surgery outpatients.
        Clin Pharmacol Ther. 1976; 20: 241-250
        • von Graffenried B
        • Nüesch E
        • Maeglin B
        • Hägler W
        • Kunh M
        Assessment of analgesics in dental surgery outpatients.
        Eur J Clin Pharmacol. 1980; 18: 479-482
        • Cooper SA
        • Breen JF
        • Giuliani RL
        Replicate studies comparing the relative efficacies of aspirin and indoprofen in oral surgery outpatients.
        J Clin Pharmacol. 1979; 19: 151-159
        • Dundee JW
        Clinical evaluation of mild analgesics.
        Br J Clin Pharmacol. 1980; 10: 329S-334S